Introduction
Thrombopoietin (Tpo), also known as the c-Mpl ligand or megakaryocyte growth and development factor (MGDF), has diverse biological eects on hematopoietic cells at various stages of maturation within the myeloid compartment (Carver-Moore et al., 1996; Cohen-Solal et al., 1997) . Tpo can synergize with other hematopoietic cytokines and stimulates the survival and proliferation of primitive, multilineage progenitor cells Ramsfjell et al., 1997; Ritchie et al., 1996) . Tpo's unique contribution to hematopoiesis is manifest in its ability to exert a highly positive in¯uence on expanding the megakaryocyte pool and facilitating the maturation of those megakaryocytes into platelet shedding cells Sitnicka et al., 1996) . Therefore, Tpo is not entirely lineage-speci®c but is still considered the primary megakaryocytopoietic and thrombopoietic regulator in vivo.
Lacking any intrinsic kinase or phosphatase activity, the Tpo receptor, c-Mpl, is a member of the hematopoietic cytokine receptor superfamily (Skoda et al., 1993; Vigon et al., 1992) . Regions of conserved sequences found in other members of this family, termed box 1 and box 2, are present on the intracellular portion of this receptor (Murakami et al., 1991) . It has been convincingly demonstrated that these two domains are highly critical for c-Mplmediated proliferation induction in a wide range of cell systems, and that deletion or mutation of either of these two domains results in an inability to activate members of the Janus kinase family, namely JAK2 and Tyk2 (Drachman and Kaushansky, 1997; Gurney et al., 1995; Morita et al., 1996) . STAT (signal transducers and activators of transcription) proteins are also potently activated through these two receptor domains (Drachman and Kaushansky, 1997; Gurney et al., 1995; Morita et al., 1996) .
A region less critical to proliferation induction, at the C-terminus of the receptor, has been shown to transmit the maturational eects of Tpo into the cell and mediates the phosphorylation/activation of c-Mpl itself as well as adapter proteins and other signaling molecules such as Shc, Grb2, Vav, SOS, and SHIP (Alexander et al., 1996; Drachman and Kaushansky, 1997; Porteu et al., 1996; Sasaki et al., 1995) . This portion of the protein is most probably responsible for activating the Ras/Raf-1/Mitogen activated protein kinase (MAPK) kinase/MAPK pathway as well, potentially downstream of Shc/Grb2/SOS complexes (Brizzi et al., 1996; Dorsch et al., 1997; Nagata and Todokoro, 1995; Rouyez et al., 1997; Yamada et al., 1995) . The p44/p42 MAPK pathway is activated by a wide range of hematopoietic cytokines and results in the upregulation of protein synthesis and immediate early gene expression, particularly that of c-fos Welham et al., 1992) . Furthermore, The MAPK pathway may play a potent and dominant role in mediating the antiapoptotic eect of hematopoietic growth factors (Kinoshita et al., 1997; Xia et al., 1995) . The current dogma is that c-Mpl contains separate structural elements, which possess unique and overlapping functions with regard to proliferation and differentiation.
In the absence of cell cycle progression, Tpo behaves as a survival factor in the human leukemic cell line M07e by suppressing apoptosis following growth factor withdrawal (Ritchie et al., 1996; . The M07e cell line originated from a child with acute megakaryoblastic leukemia, and displays surface markers characteristic of both early myeloid progenitors (CD34) and more committed members of the platelet lineage such as CD41a (Avanzi et al., 1988) . M07e cells are factor-dependent, requiring either granulocyte-macrophage colony-stimulating factor (GM-CSF) or interleukin-3 (IL-3) for growth (Avanzi et al., 1988; Hendrie et al., 1991) and have served as a useful system for studying signal transduction events following cytokine receptor antagonism. Since our subline of M07e does not proliferate in response to Tpo and is dierentiation-defective (Ritchie et al., 1996) , Tpo/M07e together constitute a model system within which we have been able to study the biological and biochemical aspects of survival factor signaling.
In the M07e cell line, we recently demonstrated that both Tpo and GM-CSF can eect a functional inactivation of the p53 tumor suppressor protein , a critical regulatory component of the apoptotic process following growth factor withdrawal in factor-dependent hematopoietic cells (Blandino et al., 1995; Yonish-Rouach et al., 1991; Zhu et al., 1994) . In accordance with the conformational hypothesis put forward by Jo Milner (Milner, 1991) , it has been demonstrated that following growth factor stimulation wild-type p53 can switch from a conformation associated with an antiproliferative, pro-apoptotic phenotype to a conformation that has a retarded ability to arrest cell cycle progression and induce apoptosis (Milner and Watson, 1990; Ritchie et al., 1997; Zerrahn et al., 1992; Zhang and Deisseroth, 1994; Zhang et al., 1992) . These two conformations are termed`suppressor' and`promoter', respectively, in regard to their phenotypic eect on cell growth (Milner, 1991) . The intracellular mechanisms involved in conformational modulation of p53 are not clear, but accumulating evidence suggests that redox regulation of three critical cysteine residues and divalent metal cation changes may play the most physiologically-relevant roles (Hainaut and Milner, 1993a,b; Rainwater et al., 1995) . If these cysteine residues, which coordinate a zinc ion in the core DNA-binding domain of p53, are either mutated or oxidized, p53 adopts the promoter conformation. However, no report to date has provided a satisfying insight into which signal transduction cascades might bridge cytokine stimulation and the molecular machinery directly conferring conformational change and functional inactivation of tumor-suppressing p53.
In this report, we demonstrate that Tpo-induced conformational changes and Tpo-enhanced survival lie downstream of the MAPK pathway in the M07e cell line, while JAK/STAT and phosphatidylinositol-3 kinase (PI-3K) signaling do not appear to play a signi®cant role in mediating this post-translational eect on p53. This data supports the notion that MAPK and JAK/STAT pathways in Tpo signaling play unique roles with regard to survival and proliferation induction, respectively. It also provides support for the argument that activation of the MAPK pathway may be the shared event by which cytokines maintain hematopoietic cell viability in lieu of proliferation induction.
Results

M07e cells contain genotypically wild-type p53
To demonstrate that Tpo is inducing a conformational and functional modulation of not only phenotypically wild-type p53 , but also genotypically wild-type p53 in M07e cells, M07e cell genomic DNA was isolated and exons 4 ± 9, which include the conserved, or hot spot regions, were bidirectionally sequenced from four PCR products. The determined sequence (not shown) lacks nucleotide substitution, addition, or deletion when compared with the frequently referenced sequence reported by Harlow et al. (1985) .
Time course of Tpo-induced upregulation of p53 in the promoter conformation
We initially determined the earliest time point at which Tpo-induced upregulation of p53 could be measured in the functionally inactivated, promoter conformation (Pab 240 + ) at or near maximal levels. After factor starving M07e cells for 18 h, 1610 6 viable cells/ml were stimulated with 50 ng/ml Tpo in serum free media for up to 24 h, with 1 ml samples taken at the times indicated in Figure 1 . Samples collected at 0, 1, 2, 4 and 8 h were washed and ®xed in a buered paraformaldehyde solution, then kept at 48C overnight and prepared for intracellular staining of p53 with the 24 h samples as described in Materials and methods. The¯ow cytometric data shown in Figure 1a reveals that Tpo-induced upregulation of Pab 240 + p53 is not clearly detectable for at least 2 h poststimulation. However, at 8 h the level of Pab 240 + p53 has reached a maximum level. It was shown previously that the protein levels of promoter conformation p53 do not noticeably change between 24 and 48 h post-stimulation . This data is compared with data generated when p53 is stained with DO-1, a monoclonal antibody that recognizes all conformations of p53. The % change in mean channel¯uorescence (MCF) between the murine IgG1a isotype control and the anti-p53 monoclonal is shown. The data shown in Figure 1b demonstrates that the ratio of promoter conformation p53 to total cellular p53 becomes increasingly smaller during Tpo stimulation, so that by 8 h post-stimulation virtually all of the total cellular p53 is in the promoter conformation. This data also suggests that Pab 240 + p53 levels can be measured as early as 8 h if so desired. It further suggests that cytokine-induced conformational change in p53 may or may not initiate immediately following receptor antagonism, but that detection of Pab 240 + p53 is very weak within the ®rst 2 h following c-Mpl activation.
Tpo induces the activation of p44/p42 MAPK in M07e cells, which is suppressed with the inhibitor PD98059 Viability factors Tpo and GM-CSF induce a conformational change in and functional inactivation of p53 in M07e cells . This is highly relevant because p53 is the molecular mediator of growth factor withdrawal-induced apoptosis, which these cytokines eectively suppress. Activation of the p44/p42 MAPK pathway has been shown to play a role in apoptosis suppression in the hematopoietic system (Kinoshita et al., 1997; Xia et al., 1995) . Since Tpo and GM-CSF have been shown to activate the MAPK pathway Rouyez et al., 1997) , it was logical to hypothesize that this pathway may play a role in p53 conformational modulation. In order to test the involvement of MAPK activity in Tpo-mediated p53 conformational change, we positively con®rmed that MAPK was activated in M07e cells following Tpo stimulation and that this activation could be suppressed with the MAPK pathway inhibitor PD98059.
PD98059, with an EC 50 of 5 mM, is a selective inhibitor of MAPK Kinase (MEK-1), shown pre- viously to markedly suppress MAPK activity in a variety of cell systems (Dudley et al., 1995; Pang et al., 1995) . We incubated factor starved M07e cells with either control media or media containing 10 mM PD98059 for 1 h, followed by a 15 min incubation in either control or Tpo-containing media. We assessed MAPK activation by ®rst immunoprecipitating the dual (Thr 202/Tyr 204) phosphorylated species of MAPK from cell lysates. Phosphorylation of MAPK on Thr 202 and Tyr 204 has been shown to be the critical event conferring enzymatic activity to MAPK (Payne et al., 1991; Sturgill et al., 1988) . The dual phosphorylated MAPK immunoprecipitates were washed with lysis buer and kinase buer and then incubated with the well-characterized MAPK target Elk-1 with non-limiting amounts of ATP. Only activated MAPK will be able to phosphorylate Elk-1 (at serine 383) in this kinase reaction assay. The reaction was terminated by the addition of 36SDS sample buer and separated by SDS ± PAGE. A Western blot was then performed using an antibody speci®c for phospho-Elk-1. The Western blot in Figure  2a shows that Tpo can dramatically induce the phosphorylation of Elk-1 and hence activation of MAPK. It also shows that PD98059 can suppress this Tpo-mediated activation of MAPK. Figure 2b shows that equal amounts of Elk-1 were included in the kinase reactions and gel loading after the membrane shown in Figure 2a was stripped and re-probed with a second, non-phospho-speci®c (pan) a-Elk-1 antibody. Half of the whole cell lysate from which MAPK was immunoprecipitated was separated by SDS ± PAGE and probed with a pan-MAPK antibody to demonstrate that the lysates contained comparable amounts of MAPK (Figure 2c ).
A
MAPK pathway plays a potent role in mediating Tpo-induced conformational changes in p53 and Tpo-enhanced viability of M07e cells Factor starved M07e cells were incubated at a density of 1610 6 viable cells/ml for 1 h in the presence or absence of 10 mM PD98059. Following this, the cells were incubated for 24 h in serum-free media containing or lacking Tpo and analysed by¯ow cytometry for the buildup of Pab 240 + p53. Figure 3a shows that only Tpo-stimulated cells possess Pab 240 + p53 when compared with time 0 or control media cultures. PD98059 suppressed the ability of Tpo to induce a conformational shift in p53 by up to 80% (P=0.021). This suggests that the MAPK pathway can play a potent role in p53 conformational change. It was shown previously that Tpo-induced conformational change in p53 coincides with nuclear exclusion and retarded DNA binding ability of p53 . Therefore, it can also be suggested that the MAPK pathway can mediate Tpo-enhanced survival by suppressing the pro-apoptotic phenotype of p53. To more directly test the role of MAPK in the Tpoenhanced survival of M07e cells, we measured apoptosis induction in M07e cells that were incubated for 1 h in the presence or absence of 10 mM PD98059 and then incubated in control media or media containing Tpo. Figure 3b reveals that Tpo was less able to maintain the viability of M07e cells pretreated with PD98059 when compared to cells pretreated with control media (P=0.033). This supports the argument that the MAPK pathway has a critical role in Tpo viability signaling and may confer that viability by functionally inactivating p53 through conformational modulation. We measured apoptosis with the Merocyanin 540 dye (MC540) which¯uoresces in the red, or FL-2, channel (Reid et al., 1996) .
To provide further evidence that the MAPK pathway is involved in the modulation of p53 conformation as well as viability maintenance, a retroviral vector (pBabe) containing a constitutively active Raf1 (pBp-Raf1-CX, Diaz et al., 1997) or the empty vector were either packaged and used to transduce M07e cells or used directly to transfect M07e cells. Transduction of M07e cells with the pBpRaf1-CX construct resulted in a signi®cant upregulation (P=50.01) of p53 in the promoter conformation in the absence of Tpo stimulation when compared with cells transduced with virus containing the empty vector ( Figure 3c ). In addition, M07e cells transduced with 6 cells/ml in serum-free media with or without 10 mM PD98059 (PD) for 1 h at 378C. Following this, these two cultures were incubated in the absence (M) or presence of 50 ng/ml Tpo (T) for 24 h. The cells were then collected and analysed for the level of promoter conformation p53 by¯ow cytometry using Pab 240 as described in Materials and methods. Data is expressed as a percent change in the mean channel uorescence (MCF) from the background isotype (IgG 1a ) control. This data represents an average of four separate experiments. (b). M07e cells were treated as in (a) except they were instead analysed for the extracellularization of phosphatidylserine using the MC540 dye as described in Materials and methods. Data is expressed as the percentage of cells that stained brightly for MC540. This data represents an average of three separate experiments. (c) 1610
6 M07e cells/ml were transduced with either pBabe vector control or pBp-Raf1-CX construct as described in Materials and methods. The cells were either prepared for intracellular detection of p53 in the promoter conformation or (d) stained with MC540 to measure apoptosis. (e) 2610 6 M07e cells/ml were transiently transfected with either pBabe vector control or pBp-Raf1-CX construct as described in Materials and methods. The cells were either prepared for intracellular detection of p53 in the promoter conformation or (f) stained with MC 540 to measure apoptosis the pBp-Raf1-CX and grown in the absence of Tpo for 24 h had a signi®cantly lower apoptotic population when compared with the control vector cultures as shown in Figure 3d (P=0.015). The M07e cells that were transiently tranfected with pBp-Raf1-CX also contained a signi®cant level (P=50.01) of p53 in the promoter conformation in the absence of Tpo stimulation when compared with M07e cells transfected with the empty vector (Figure 3e ). M07e cells transfected with pBp-Raf1-CX displayed a lower apoptotic rate in the absence of Tpo stimulation when compared with those transfected with the empty vector as shown in Figure 3f (P=0.038). A MAP kinase assay was performed to measure levels of MAPK activity in both the transduced and transfected M07e cells. Figure  4 demonstrates that M07e cells transduced with the pBp-Raf1-CX construct possessed a high level of activated MAPK in the absence of Tpo stimulation. M07e cells transfected with the pB-Raf1-CX construct also possessed elevated levels of MAPK activity, albeit lower than the transduced cells or cells stimulated with Tpo. We con®rmed equal amounts of MAPK protein in the cell lysates (data not shown).
Using MC540, which detects phosphatidylserine buildup on the outer lea¯et of the plasma membrane (a physiologically relevant event in the early stages of apoptosis), we were able to determine the percentage of cells undergoing apoptosis at the given time points bȳ ow cytometry (Reid et al., 1996) . As shown in the left side of Figure 5a , M07e cells factor starved for 36 h that are almost 50% non-viable as measured by trypan blue exclusion (Ritchie et al., 1996) , contain an MC540 dim and an MC540 bright population (Figure 5b ). GM-CSF-stimulated cells that were in log-phase growth at 36 h, were predominantly MC540 dim. By sorting the MC540 bright cells from the MC540 dim cells in the factor-starved cultures through¯uorescence activated cell sorting (FACS), it can be seen that MC540 dim cells possess`normal' forward (cell size, FSC) vs side (cell density, SSC) scatter pro®le ( Figure  5c ) similar to factor-stimulated cultures ( Figure 5a ) and a healthy-looking, blastic morphology (Figure 5d ). In comparison, MC540 bright cells represent a smaller, denser population of cells by forward vs. side scatter pro®le and have typical apoptotic morphology. Furthermore, sorting on MC540 dim vs bright cells previously revealed that the MC540 bright cells possessed a subdiploid content of DNA that was fragmented (a hallmark of apoptosis) using the Hoechst 33342 dye and conventional electrophoresis (Reid et al., 1996) . That study also revealed that the MC540 dim cells were diploid and did not contain fragmented DNA. In our analyses, a marker was drawn in between the MC540 bright and dim populations (as shown in Figure 5b as M1) and the percentage of cells residing within that MC540 bright population was determined.
It was possible that PD98059 was inducing apoptosis in a p53-independent manner resulting in an indirect retardation of Tpo-mediated viability enhancement. To resolve this issue, the protein levels of p53 were negated in M07e cells with antisense oligonucleotides, that have been successfully used in previous studies to markedly suppress p53 protein expression (Bi et al., 1993; Ritchie et al., 1997) . As shown in Figure 6a , M07e cells treated with the antisense oligonucleotides were markedly resistant to PD98059-induced apoptosis when compared to the scrambled sense oligos (P=0.008). This is Figure 4 M07e cells transduced or tranfected with pBp-Raf1-CX contain elevated levels of MAPK activity in the absence of Tpo stimulation. Either 1610 6 M07e cells/ml were transduced or 2610 6 M07e cells/ml were transiently transfected with either pBabe vector control or pBp-Raf1-CX construct as described in Materials and methods. Cell lysates were prepared and a MAPK assay was performed as described in Materials and methods and in the legend to Figure 2 MC540 dye used to detect apoptosis. 1610 6 M07e cells were either factor starved for 36 h or factor stimulated for 36 h with 100 U/ml GM-CSF. The cells were collected and stained with 400 ng/ml MC540 as described in Materials and methods. convincing evidence that the PD98059-induced death in the presence of survival factor stimulation is predominantly a p53-dependent process in M07e cells. Furthermore, it strengthens the argument that p53 is a downstream target of MAPK-mediated suppression of apoptosis. Figure 6b shows that the p53-speci®c antisense oligonucleotides were eective in suppressing p53 protein levels during these assays when detected with conformation-independent p53 antibody DO-1. Figure 6c shows that the cell lysates contained comparable amounts of protein as measured by glyceraldehyde-3 phosphate dehydrogenase protein levels.
JAK/STAT signaling plays an insigni®cant role in mediating Tpo-induced conformational changes in p53 and Tpo-enhanced viability of M07e cells It has been shown repeatedly that JAK2, and to a lesser degree Tyk2, are the two members of the JAK family activated by Tpo stimulation (Drachman and Kaushansky, 1997; Gurney et al., 1995; Morita et al., 1996) . We wanted to determine if the JAK2 tyrosine kinase is activated in our subline of M07e cells following Tpo stimulation. It has been previously demonstrated that JAK2, but not Tyk2, is activated by Tpo in M07e cells, but the subline of M07e cells used in that study respond proliferatively to this cytokine , while our M07e subline does not proliferate well in response to Tpo (Ritchie et al., 1996) . It was therefore possible that Tpo was not activating JAK2 in our subline. 1610 6 factor starved and viable M07e cells were incubated for 30 min in either control media or media containing Tpo. Following this, JAK2 was immunoprecipitated from the cell lysates. After transfer to PVDF membranes, JAK2 was probed with anti-phosphotyrosine antibodies to measure the degree of JAK2 phosphorylation, which is in turn an indirect measure of activation (Stahl et al., 1994) . Figure 7a shows that JAK2 is markedly tyrosine-phosphorylated in M07e cells following Tpo-stimulation. Equal JAK2 protein content in the immunoprecipitates was demonstrated with a-JAK2 antibody. To substantiate the use of Tyrphostin AG490, which blocks JAK2 kinase activity with relative selectivity (Meydan et al., 1996) , we measured the level of phosphorylated STAT5, a direct downstream target of JAK2, by immunoprecipitating STAT5 from lysates of Tpo-stimulated M07e cells preincubated with, or without, 0.3 mM of the AG490 Figure 6 Negation of p53 protein levels with anti-sense oligonucleotide reverses the negative eects of PD98059 on Tpo-enhanced cellular viability. (a) 1610 6 M07e cells/ml were incubated with 5 mM of either antisense or scrambled sense p53-speci®c oligonucleotides for 36 h in serum-free media. The cells were then incubated for 1 h at 378C with or without 10 mM PD98059 (PD). Following this, the cells were incubated for 48 h in the absence (M) or presence of 50 ng/ml Tpo (T) and then analysed for apoptosis with the MC540 dye as described in Materials and methods. This data represents an average of three separate experiments. (b) Western blot analysis of whole cell lysates taken at 48 h to con®rm that p53 antisense oligonucleotides were suciently suppressing p53 protein expression. This experiment was performed three times yielding similar results. (c) Equal loading of cell lysates was con®rmed with anti-GAPDH by Western blot analysis Figure 7 JAK2 and STAT5 are tyrosine phosphorylated in our subline of M07e cells that do not respond proliferatively to Tpo. JAK2 inhibitor AG490 markedly suppresses STAT5 tyrosine phosphorylation (a) 1610 6 factor starved M07e cells/ml were incubated for 30 min in control serum-free media or media containing 50 ng/ml Tpo (T). The cells were then lysed and JAK2 immunoprecipitated. Following transfer to PVDF membranes, the level of tyrosine phosphorylated JAK2 was detected with a 1 : 1 mixture of a-phosphotyrosine (P-Tyr) clones 4G10 and PY99. Media (M) and Tpo (T) samples are compared to factor starved, time 0 lysates (0). The bottom panel shows that the immunoprecipitates all contained comparable amounts of JAK2. This experiment was performed three times yielding similar results. (b) Factor starved M07e cells were incubated at 1610 6 cells/ml in serum-free media with or without 0.3 mM AG490 (AG) for 1 h at 378C. Following this, these two cultures were incubated in the absence (M) or presence of 50 ng/ml Tpo (T) for 15 min. The cells were collected, lysed, and STAT5 immunoprecipitated. Following transfer to PVDF membranes, the level of tyrosine phosphorylated STAT5 was detected with a 1 : 1 mixture of a-phosphotyrosine (P-Tyr) clones 4G10 and PY99. Media (M) and Tpo (T) samples are compared to factor starved, time 0 lysates (0). The bottom panel shows that the immunoprecipitates all contained comparable amounts of STAT5. This experiment was performed three times yielding similar results compound and subsequently determined the tyrosine phosphorylation status of STAT5 with a 1 : 1 mixture of a-phosphotyrosine clones 4G10 and PY99. It has been previously demonstrated that tyrosine phosphorylation of STAT5 in M07e cells coincided with its ability to form DNA bound complexes . Figure 7b shows that AG490 treated cells have a marked decrease in phosphorylated STAT5 protein levels, suggestive of suppressed activation of JAK2. Equal STAT5 protein content in the immunoprecipitates was demonstrated with a-STAT5 antibody.
We wanted to test the possibility that JAK signaling in M07e cells may potentially play a role in p53 conformational change and viability in M07e cells. With regard to p53 conformational change, AG490 had very little eect as compared to control Tpotreated cells (P=0.300) when these cells were analysed by¯ow cytometry (Figure 8a ). In addition, AG490 did not have a notable eect on Tpo-enhanced viability in M07e cells (Figure 8b ) when stained with the MC540 dye. This set of data indicates that JAK signaling may not play a signi®cant role in Tpo-induced conformational changes in p53, nor in mediating apoptosis suppression directly.
One report provided evidence that, in contrast to STAT5, STAT3 phosphorylation may not completely parallel JAK2 phosphorylation (Drachman and Kaushansky, 1997). The box 1 and 2 domains, which mediate JAK2, STAT5, and STAT3 phosphorylation, were shown to be critical for proliferation. Two tyrosines in the 10 C-terminal residues of c-Mpl can mediate STAT3 phosphorylation as well but play a less vital role in mitogenesis. One of these two latter tyrosines is also critical for Shc phosphorylation, which is believed to couple c-Mpl with the Ras/Raf-1/MAPK pathway. In addition, STAT3 can be activated at Ser 727 by MAPK (Chung et al., 1997) , which may account for STAT3 being activated through the C-terminal portion of c-Mpl. It has also been demonstrated that STAT3 may play a role in suppressing apoptosis (Fukada et al., 1996) .
We therefore wanted to test the individual role of STAT3 in p53 conformational changes and viability. Using an antisense oligonucleotide that was directed against the mRNA of human STAT3 using the same codon targeting strategy as the p53 antisense oligonucleotides, we were able to diminish the protein levels of STAT3 by over 50%, when compared with scrambled sense oligonucleotide treatment, and roughly 65% when compared to media control. 1610 6 factor starved and viable M07e cells were incubated for 48 h in serum free media alone or containing 50 ng/ml Tpo each with or without 10 mM of STAT3-speci®c oligonucleotide sequences. At 48 h, the cells were collected, lysed and the protein content between samples adjusted equally. Western blotting of PVDF membranes (probed with an a-STAT3 antibody) is shown in Figure 9 . Figure 10a and b show that neither the antisense or scrambled sense oligonucleotides have a signi®cant eect on Tpo-induced conformational changes in p53 (P=0.507 for AS, P=0.251 for SS) or on Tpo-enhanced survival (P=0.776 for AS, P=0.695 for SS) of M07e cells when analysed bȳ ow cytometry at 24 and 48 h, respectively. To allow sucient time for STAT3 protein expression diminishment, we supplemented the media during an initial 24 h incubation period with Tpo to maintain cellular integrity. The STAT3 antisense oligonucleotides were eective biologically, as they markedly suppressed Tpo and GM-CSF induced synergistic proliferation as measured by tritiated thymidine incorporation when compared to the scrambled sense oligos (data not 6 cells/ml in serum-free media with or without 0.3 mM AG490 (AG; a JAK2 inhibitor) for 1 h at 378C. Following this, these two cultures were incubated in the absence (M) or presence of 50 ng/ml Tpo (T) for 24 h. The cells were then collected and analysed for the level of promoter conformation p53 by¯ow cytometry using Pab 240 as described in Materials and methods. Data is expressed as a percent change in the mean channel¯uorescence (MCF) from the background isotype (IgG 1a ) control. This data represents an average of three separate experiments. (b) Factor starved M07e cells were incubated at 1610 6 cells/ml in serum-free media with or without 0.3 mM AG490 (AG) for 1 h at 378C. Following this, these two cultures were incubated in the absence (M) or presence of 50 ng/ml Tpo (T) for 48 h. The cells were then collected and analysed for the extracellularization of phosphatidylserine using the MC540 dye as described in Materials and methods. Data is expressed as the percentage of cells that stained brightly for MC540. This data represents an average of three separate experiments shown). These data suggests that, although the two Cterminal tyrosine residues of c-Mpl may confer the anti-apoptotic eects of Tpo, and are potentially involved in STAT3 activation, STAT3 alone does not appear to play a substantial role in Tpo-enhanced suppression of p53-mediated growth factor withdrawalinduced apoptosis. It also suggests that complete suppression of STAT3 protein levels is not required to abrogate synergistic proliferation induction. The fact that STAT3 does appear to be involved in at least synergistic proliferation in our subline of M07e cells further strengthens the argument that Tpo induces proliferation and dierentiation/survival through two separate mechanisms.
Phosphatidylinositol-3-phosphate Kinase (PI-3K) plays an insigni®cant role in Tpo-induced conformational changes in p53
Some reports have demonstrated the ability of Tpo to activate PI-3K, which has been shown to suppress apoptosis in some cell systems (PaÂ rrizas et al., 1997; Sattler et al., 1997; Zauli et al., 1997) . We therefore tested the involvement of PI-3K in p53 conformational change and Tpo-enhanced viability in M07e cells using wortmannin, a well-characterized inhibitor of PI-3K activity that we have previously shown to be biologically eective at a signi®cant level in this cell line Takahira et al., 1997) . Factor starved M07e cells were pretreated with either control media or media containing 0.5 mM wortmannin for 1 h. Figure 11a shows that wortmannin did not have a signi®cant eect on Tpo-induced conformational change in p53 (P=0.664) when used alone. Nor did wortmannin augment or enhance PD98059's eect on p53 conformational changes (data not shown). However, wortmannin did weakly but signi®cantly block the ability of Tpo to suppress apoptosis (P=0.019) as shown in Figure 11b .
The data presented herein demonstrates that MAPK has the principal ability to mediate Tpo-induced conformational changes in p53. It also demonstrates that MAPK is the major apoptosis-suppressing subsystem within the cell following Tpo stimulation, with PI-3K playing a minor and potentially contributory role in Tpo's anti-death activities.
Discussion
Cells of the hematopoietic system die by apoptosis when deprived of growth or viability factors (Williams 6 cells/ml were incubated in serum-free media with or without 10 mM STAT3 antisense (AS) or scrambled sense (SS) oligonucleotides plus 50 ng/ml Tpo (to maintain cellular viability) for 24 h at 378C. These cultures were then incubated in the absence (M) or presence of 50 ng/ml Tpo (T) for 24 h. The cells were collected and analysed for the level of promoter conformation p53 by¯ow cytometry using Pab 240 as described in Materials and methods. Data is expressed as a percent change in the mean channel¯uorescence (MCF) from the background isotype (IgG 1a ) control. This data represents an average of three separate experiments. (b) 1610 6 cells/ml were incubated in serum-free media with or without 10 mM STAT3 antisense (AS) or scrambled sense (SS) oligonucleotides plus 50 ng/ml Tpo (to maintain cellular viability) for 24 h at 378C. These cultures were then incubated in the absence (M) or presence of 50 ng/ml Tpo (T) for 48 h. The cells were collected and analysed for the extracellularization of phosphatidylserine using the MC540 dye as described in Materials and methods. Data is expressed as the percentage of cells that stained brightly for MC540. This data represents an average of three separate experiments et al., 1990). It has been convincingly shown that this death process can be moderated by p53 (Blandino et al., 1995; Yonish-Rouach et al., 1991; Zhu et al., 1994) . The over-expression of wild-type p53 in p53-de®cient leukemic cells induces cell death that is suppressible by hematopoietic cytokines such as SLF, IL-3, IL-6, and erythropoietin (Epo), while the introduction of dominant negative mutant p53 retards the apoptotic process following growth factor withdrawal (Abrahamson et al., 1995; Blandino et al., 1995; YonishRouach et al., 1991) . It follows that hematopoietic cytokines must somehow counteract p53 activity by either functionally disabling p53, by suppressing downstream targets of p53, or suppressing p53 protein expression.
Conformational modulation appears to be one way through which p53 is functional inactivated during cytokine stimulation, for when p53 adopts the promoter conformation it is sequestered from the nucleus and, more importantly, is greatly weakened in its ability to bind DNA (Hainaut and Milner, 1993a; Ritchie et al., 1997; Zerrahn et al., 1992) . These events can be translated into an inability of p53 to upregulate the expression of pro-apoptotic bax and downregulate anti-apoptotic bcl-2. Although a considerable amount of work is being done in an eort to understand the molecular mechanics of this conformational change, details concerning the signaling pathways employed during cytokine signaling which interface with the p53-modifying machinery have yet to be reported. Of clinical interest, AML samples most commonly contain wild-type p53, but in the promoter conformation as a function of growth stimulation (Zhang et al., 1992) . In vivo, it is conceivable that cytokines may contribute to leukemogenesis by functionally inactivating p53, via MAPK pathway-mediated conformational modulation, in a hematopoietic cell that possesses an activated proto-oncogene such as dysregulated c-Myc or dysregulated p21
Ras capable of co-transformation with mutant' p53. Identi®cation of signal transduction cascades and molecular machinery that lead to this altered state of p53 could narrow eorts towards ®nding chemo-therapeutic targets which would restore p53 activity and enhance chemo-and radio-sensitivity in these cells.
We report here that a signal transduction pathway ubiquitously activated during hematopoietic cytokine stimulation, the MAPK pathway, is largely responsible for eecting the conformational modulation in p53. This eect was relatively free of in¯uence from JAK/ STAT and PI-3K activities. The fact that JAK2 as well as STAT5 appear to be activated normally following Tpo stimulation in our subline of M07e cells lessens the possibility that a dysfunctional JAK/STAT pathway exists. This suggests that the MAPK pathway may be at least partially involved in uncoupling the proliferative and survival-inducing eects of Tpo. However, the MAPK pathway appears to also be involved in megakaryocytic dierentiation (Dorsch et al., 1997; Melemed et al., 1997) . We could not test this in M07e cells since they do not appear to be capable of dierentiating.
Hypothetically, dierentiation and p53-suppressive signals transmitted through the same pathway would prove bene®cial to a developing megakaryocyte. The endomitotic process that ensues during megakaryocytopoiesis would present itself as genetic ampli®cation to p53, one of the events which p53 speci®cally prevents. Therefore, using a common signaling pathway would ensure that if the signal to become polyploid were initiated in a megakaryocyte, a signal would also be simultaneously generated which suppresses cellular sentinels that detect polyploidization and prohibit DNA synthesis, such as p53. 6 cells/ml in serum-free media with or without 0.5 mM wortmannin (W) for 1 h at 378C. These two cultures were then incubated in the absence (M) or presence of 50 ng/ml Tpo (T) for 24 h. The cells were then collected and analysed for the level of promoter conformation p53 by¯ow cytometry using Pab 240 as described in Materials and methods. Data is expressed as a percent change in the mean channel¯uorescence (MCF) from the background isotype (IgG 1a ) control. This data represents an average of three separate experiments. (b) Factor starved M07e cells were incubated at 1610 6 cells/ml in serum-free media with or without 0.5 mM wortmannin (W) for 1 h at 378C. These cultures were then incubated in the absence (M) or presence of 50 ng/ml Tpo (T) for 48 h. The cells were collected and analysed for the extracellularization of phosphatidylserine using the MC540 dye as described in Materials and methods. Data is expressed as the percentage of cells that stained brightly for MC540. This data represents an average of three separate experiments
The next logical question is; where does the MAPK pathway actually interface with the conformational machinery? Is it necessarily a phosphorylation event? Some evidence suggests that the upregulation of p53 in the promoter conformation is independent of changes in phosphorylation (Milne et al., 1994) . However, murine p53 is a substrate for MAPK activity in vitro (Picksley et al., 1992 ). We have not tested for changes in p53 phosphorylation status during cytokine stimulation in M07e cells. Genetic analysis of the MAPK cascade will certainly prove useful in elucidating what pathway components are involved in this process. In addition, any relationship the MAPK pathway may have with intracellular redox subsystems that potentially regulate the redox state of p53, namely glutathione and thioredoxin, would warrant investigation. Our observation that PI-3K is somewhat involved in suppressing apoptosis, but not in the conformational modulation of p53, opens up the possibilities that conformational modulation of p53 is not the only means of suppressing p53-mediated apoptosis through Tpo signaling, that Tpo may suppress apoptosis in a p53-dependent and p53-independent manner and that both of these last two scenarios are in eect. For example, Akt, which can be activated by cytokine signaling through PI-3K, can induce the phosphorylation and inactivation of Bad, a pro-apoptotic member of the Bcl-2 family that can functionally substitute for Bax (Franke et al., 1995; Yang et al., 1995) . Although the ability of p53 to transactivate bad has yet to be conclusively demonstrated, p53 is a potent modulator of other Bcl-2 family member protein levels and may also contribute to raising Bad protein levels (Miyashita and Reed, 1995) . The role MAPK plays with regard to apoptosis suppression certainly appears to be dominant to the role PI-3K plays in this cytokine/cell system. PI-3K may therefore supplement the anti-apoptotic activities of MAPK while serving another more vital function such as adhesion or proliferation induction (Dorsch et al., 1997; Takahira et al., 1997; Zauli et al., 1997) .
Materials and methods
Cytokines, cells and reagents
Recombinant human (rhu) GM-CSF was a kind gift of the Immunex Corp. and rhuTpo was purchased from R&D Systems. Concentrations used in these assays were 100 U/ ml for GM ± CSF and 50 ng/ml for Tpo. The human growth factor-dependent subline, M07e, was obtained from Genetics Institute (Boston, MA). The M07e subline, and its parental line M07, have been biologically characterized previously (Avanzi et al., 1988; Hendrie et al., 1991; Miyazawa et al., 1991) . M07e cells were maintained in RPMI 1640 (Bio Whittaker) with 20% heat inactivated fetal bovine serum (FBS) with 100 U/ml GM ± CSF. Factor starvation was accomplished by washing day 3 or day 4 cells twice with RPMI 1640 and incubating them for 18 h in RPMI 1640 with 0.1% bovine serum albumin (BSA) to synchronize the cells in G 0 /G 1 of the cell cycle and remove residual GM ± CSF and serum-induced signals. Serum-free media consisted of RPMI 1640 with 2% dilipidated, deionized and dialyzed BSA, 10 mg/ml insulin, 200 mg/ml saturated human transferrin, 50 mM beta-mercaptoethanol, 40 mg/ml LDL, all from Sigma Chemical Co. All other reagents were purchased from Sigma except the following: Merocyanin (MC 540) was purchased from Molecular Probes. The MEK-1 inhibitor PD98059 and the MAPK assay kit were purchased from New England Biolabs and JAK2 inhibitor AG490 was purchased from Calbiochem.
Flow cytometric analysis
For¯ow cytometric detection of intracellular protein levels, 1610 6 cells were collected at the indicated time points per condition and washed in PBS with 0.1% BSA. The samples were then simultaneously permeabilized and ®xed in 500 ml of a 4% paraformaldehyde, 0.1% saponin, 10 mM HEPES solution for 15 min at 48C. Cells were then washed twice with PBS with 0.1% BSA and incubated with 1 mg/ml of the primary antibody or appropriate isotype control for 20 min at 48C. After washing twice, the samples were incubated with the appropriate secondary FITC-or Tri Color (TC)-conjugated antibody for 20 min. Stained cells were then washed and resuspended in 400 ml of a 4% paraformaldehyde 10 mM HEPES solution for¯ow cytometric analysis. Ten thousand events were collected per sample. For staining M07e cells with MC540, 20 (L of working stock (10 mg/ml) is added to 1 ± 10610 6 cells in 500 ml of PBS. This staining solution/cell suspension is incubated at room temperature for 15 min, and washed once with PBS. MC540 is analysed in the FL2 channel on a logarithmic scale. The amplitude gain of the FL2 channel was adjusted so that the MC540 dim peak had a mean channel¯uorescence of *10. A marker was set between the MC540 dim and MC540 bright populations and the cells that resided within the marker were considered positive (Reid et al., 1996) . For the sorting experiment, MC540 dim from MC540 bright cells were separated on a Becton Dickinson FACS sorter based upon FL2 intensity. 1610 6 cells were collected from each of these two populations into PBS. Morphological examination of these cells was carried out by gently centrifuging (500 g for 4 min) M07e cells onto microscope slides in a cytospin apparatus (Shanndon). Slides were stained with a Hema-tek machine using Wright-Giemsa. Pictures were taken with a scopeintegrated camera at 10006 magni®cation under oil immersion.
Antibodies, Western blotting and immunoprecipitations
Antibodies used in these studies include; a-p53 (Pab 240), an IgG 1 murine monoclonal that recognizes the promoter conformation of p53, and pan a-MAPK were purchased from Oncogene Science. a-dual phosphorylated-MAPK, a murine monoclonal and a-phospho-Elk-1, a rabbit IgG polyclonal, were both purchased from New England Biolabs. a-p53 (DO-1), an IgG murine monoclonal which recognizes all forms of p53, a-JAK2, an IgG rabbit polyclonal, a-STAT3, an IgG rabbit polyclonal, a-STAT5, an IgG rabbit polyclonal, a-Elk-1, an IgG rabbit polyclonal, and a-phosphotyrosine (PY99), a murine IgG monoclonal, were all purchased from Santa Cruz Biotechnology, Inc. a-glyceraldehyde-3 phosphate dehydrogenase (GAPDH) was purchased from Biodesign International. Anti-phosphotyrosine (anti-p-Tyr) 4G10 murine monoclonal was purchased from Upstate Biotechnology. All secondary, HRP-labeled antibodies were purchased from Amersham Life Science. All secondary,¯uorochrome-conjugated antibodies as well as¯ow cytometric isotype controls were purchased from Caltag. Cells were lysed in ice cold 50 mM Tris, 150 mM NaCl, 5 mM EDTA, 1% NP-40, with common inhibitor cocktail added. Lysates analysed by Western blot were adjusted for total protein content and equal protein amounts were loaded per well. Samples were separated by SDS ± PAGE and transferred to Immobilon-P membranes (Millipore), blocked with 2% BSA, probed and developed with ECL Western blot detection kit (Amersham Life Science). Immunoprecipita-tions were performed as previously described (Tauchi et al., 1994) . Brie¯y, cell lysates were incubated with appropriate antibody for 4 h at 48C on a rotary drum. Immunoprecipitates were collected by protein A/G agarose beads (Santa Cruz Biotechnology) and were gently washed ®ve times before being resuspended in SDS ± PAGE loading buer.
Antisense oligonucleotides
The 18-mer phosphorothiolated p53-and STAT3-speci®c oligonucleotides were synthesized by an automated process (Biotechnology Facility, Indiana University). The sequences of the p53-speci®c oligonucleotides were; 5'-CGG CTC CTC CAT GGC AGT-3' (antisense); 5'-CAA GGA GTA GGC ACC GGT-3' (scrambled sense). The target region of p53 mRNA, the anity for the target region, and the translation inhibition eciency have been described previously (Bi et al., 1993) . The oligonucleotides were resuspended at a ®nal concentration of 5 mM in serum-free assay medium. STAT3-speci®c oligonucleotides were; 5'-CCA TTG GGC CAT CCT GTT-3' (antisense); 5'-CAA GGA GTA GGC ACC GGT-3' (scrambled sense). The STAT3 antisense oligonucleotides target the -1 and -2 and ®rst four codons of the human STAT3 mRNA. Cells were incubated with oligonucleotides during a 24 h factor starvation or Tpo-stimulation period and up to 72 h post-stimulation, with addition of fresh oligos every 24 h.
MAPK activity assay
The MAPK activity assay kit was purchased from New England Biolabs. 2610 6 cells per well of a six well plate were collected by centrifugation and washed with ice cold PBS. Cells were lysed on ice for 20 min and the supernatant collected by microcentrifugation for 10 min at 18 000 g at 48C. To 200 ml of lysate was added 2 ml of aphospho-MAPK and this was incubated overnight on a rotary drum at 48C. Fifty ml of 50% protein A/G-agarose was added to this mixture and incubated on a rotary drum for 3 h at 48C. The agarose pellet was collected, washed twice with lysis buer and twice with kinase buer (both supplied by the New England Biolabs). The agarose pellet was resuspended in 50 ml kinase buer with 1 ml of 10 mM ATP and 1 ml (2 mg/mL) of Elk-1 fusion protein. These kinase cocktails were incubated at 338C for 30 min and terminated with 25 ml of SDS±PAGE sample buer. Twenty ml of this was separated on a 10% SDS ± PAGE. The membrane was probed with a-phospho-Elk-1. This assay detects Elk-1 that has been phosphorylated at Ser 383, the site of phosphorylation by MAPK.
Genomic DNA isolation and sequencing
Genomic DNA was isolated with the PureGene kit (Gentra Systems, Minneapolis, MN, USA) and the sequence of exons 4 ± 9 of p53 was determined in a bi-directional and overlapping fashion by Cybergene Corporation (Sweden) using proprietary primers. The determined genomic sequence of M07e cell p53 was compared to that reported by Ed Harlow and colleagues (Harlow et al., 1985) .
Transfections, transductions and plasmids
Dr Mark Marshall generously provided the plasmid pBpRaf1-CX (Diaz et al., 1997) based on the retroviral vector pBabepuro (Morgenstern and Land, 1990) . pBp-Raf1-CX contains the Ki Ras 17 amino acid membrane localization signal. Isoprenylation of this sequence leads to plasma membrane association and constitutive activation of Raf1 kinase. In pBp-Raf1-CX, the activated Raf1-CX is transcriptionally regulated by the Molony Murine Leukemia Virus LTR and puromycin resistance gene is transcriptionally regulated by the SV40 early promoter. M07e cells (1610 6 cells/0.5 ml DMEM) were transfected with the 10 mg of the expression vectors by electroporation (0.22 v, 960 mF) in 4 mm cuvettes (Midwest Scienti®c) with Gene Pulser Transfection Apparatus (BioRad). The pBabepuro and pBp-Raf1-CX retroviral vectors were shuttle packaged through BOSC23 ecotropic packaging cells (Pear et al., 1993) into PA317 amphotropic packaging cells (Miller and Buttimore, 1986) . M07e cells were transduced with supernatants collected from PA317 cells. Transfected and transduced cells were cultures and stained for p53 con®rmation and apoptosis as previously described.
Statistical analysis
Samples were compared for statistically signi®cant differences using the Student's t-test to derive a P value. All error bars represent standard deviation (s.d.).
